CD44 and breast carcinoma: On the basis of the observation that VEGF C is predominately expressed in the claudin-low subtype of breast cancer, which is known to have TIC features, we next sought to determine whether VEGF C expression correlates with a TIC or cancer stem cell signature previously created using CD44+/CD24− expression [30],[31].